Cefotaxime Sodium API Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period. Cefotaxime Sodium API is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime Sodium API binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, Cefotaxime Sodium API is more active against gram-negative bacteria and less active against gram-positive bacteria. IMR offers a comprehensive overview of the market through the analysis of key parameters such as revenue, price, compet...